Osteoporosis, cardiovascular disease, cancer, infection . . . which of these comorbidities are of greatest concern in patients with SpA?
Reference1. Moltó A, Nikiphorou E. Comorbidities in spondyloarthritis. Front Med. 2018;5:62. doi:10.3389/fmed.2018.00062.
Moltó and Nikiphorou have reviewed the various comorbidities associated with spondyloarthritis (SpA) in an effort to improve outcomes through education and understanding.1
Scroll through the slides for an overview of the current knowledge base and for take-home points for clinicians.